---
schema_version: "secwatch.filing_event.v1"
accession: "0001193805-25-000454"
form_type: "8-K"
ticker: "IMUX"
cik: "0001280776"
company_name: "IMMUNIC, INC."
filed_at: "2025-04-09T23:59:59+00:00"
generated_at: "2026-05-23T18:01:39.959507+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Immunic prices $5.1M registered direct offering of 5.67M shares at $0.90/share

## Summary
- Offering led by Aberdeen Investments; Titan Partners as placement agent.
- Gross proceeds ~$5.1M; net proceeds ~$4.6M after commissions and expenses.
- Shares sold at $0.90 per share under existing shelf registration statement.
- Expected to close on April 10, 2025; proceeds to fund clinical trials and operations.

## SEC filing metadata
- accession: 0001193805-25-000454
- form_type: 8-K
- ticker: IMUX
- cik: 0001280776
- company_name: IMMUNIC, INC.
- filed_at: 2025-04-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1280776/000119380525000454/0001193805-25-000454-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1280776/000119380525000454/e664373_8k-immunic.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193805-25-000454
- JSON: https://secwatch.observer/filing/0001193805-25-000454.json
- Plain text: https://secwatch.observer/filing/0001193805-25-000454.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.